Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
474.57
+4.29 (+0.91%)
Official Closing Price
Updated: 4:15 PM EDT, Jul 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
44
45
Next >
Got $5,000? Buy and Hold These Fast-Growing Stocks for Years
April 18, 2023
These companies have doubled their sales within the past five years.
Via
The Motley Fool
3 High-Growth Biotech Stocks Poised for Success in 2023
April 18, 2023
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity
Via
InvestorPlace
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now
April 18, 2023
These stocks should hold up quite well regardless of what happens with the U.S. economy.
Via
The Motley Fool
The Top Healthcare Stocks to Buy With $100
April 18, 2023
A small investment now may bring big results over time.
Via
The Motley Fool
Why CRISPR Therapeutics Stock Is Marching Higher Today
April 17, 2023
This gene-editing stock has been heating up over the past week.
Via
The Motley Fool
Genmab Stock Hits 80-Plus Relative Strength Rating Benchmark
April 17, 2023
On Monday, Genmab stock saw its Relative Strength (RS) Rating jump into the 80-plus percentile, rising to 84, up from 80 the day before.
Via
Investor's Business Daily
Is CRISPR Therapeutics Stock a Buy Now?
April 14, 2023
The biotech could soon be a commercial-stage company.
Via
The Motley Fool
CRISPR Stock: Bull vs. Bear
April 08, 2023
CRISPR's first approved product may be right around the corner.
Via
The Motley Fool
Why Shares of Editas Medicine Rose Monday
April 17, 2023
The company is benefiting from positive news affecting other gene-editing stocks.
Via
The Motley Fool
Which Stocks Pass Warren Buffett's $10,000 Test?
April 17, 2023
Buffett's recent CNBC interview raises an interesting question.
Via
The Motley Fool
Prediction: These Will Be 3 of the Biggest Monster Stocks of the Decade
April 17, 2023
They're already highly successful. But there's a lot more room to run.
Via
The Motley Fool
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
April 13, 2023
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks.
Via
InvestorPlace
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
Via
Benzinga
2 Nasdaq Growth Stocks That Are Screaming Buys in April
April 13, 2023
Massive drivers of fresh earnings are drawing closer, and risks are declining.
Via
The Motley Fool
Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades'
April 13, 2023
On CNBC’s "Halftime Report Final Trades," Anastasia Amoroso of JP Morgan Private Bank named iShares Preferred and Income Securities ETF (NYSE: PFF) as her
Via
Benzinga
Could This Move Make Vertex's Next Blockbuster Even Bigger?
April 12, 2023
Vertex is showing it can branch out beyond its cystic fibrosis specialty.
Via
The Motley Fool
My 5 Top Stocks to Buy in April
April 10, 2023
These stocks share one primary common denominator -- great growth prospects.
Via
The Motley Fool
2 Winning Stocks That Could Turn $10,000 into $50,000 by 2030
April 09, 2023
These stocks have growth stories that could supercharge returns over the long run.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in a New Bull Market
April 08, 2023
These stocks have what it takes to soar if and when a new bull market begins.
Via
The Motley Fool
Nasdaq Bear Market: 5 Astonishing Growth Stocks You'll Regret Not Buying on the Dip
April 08, 2023
A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on discounted growth stocks.
Via
The Motley Fool
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market
April 07, 2023
These stocks have growth stories that investors might find too compelling to overlook.
Via
The Motley Fool
A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right Now
April 07, 2023
Don't let these superior stocks pass you by.
Via
The Motley Fool
2 Smartest Growth Stocks to Buy Without Hesitation Right Now
April 06, 2023
A turbulent market is still full of opportunity for shrewd investors.
Via
The Motley Fool
Where to Invest $2,500 Right Now
April 06, 2023
Even another bear market doesn't need to deter investors with the appropriate buy-and-hold horizon.
Via
The Motley Fool
2 Top Stocks to Buy Before the Next Nasdaq Bull Market
April 06, 2023
Tough market conditions will eventually give way to the next bull run on stocks.
Via
The Motley Fool
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
April 06, 2023
Via
Benzinga
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
April 04, 2023
Vertex shares are on the rise.
Via
The Motley Fool
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
April 03, 2023
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.
Via
Talk Markets
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
April 03, 2023
Via
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.